Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: E9AWT6
Term | Name | Level | Count |
---|---|---|---|
GO:0043085 | positive regulation of catalytic activity | 4 | 1 |
GO:0043087 | regulation of GTPase activity | 5 | 1 |
GO:0043547 | positive regulation of GTPase activity | 6 | 1 |
GO:0044093 | positive regulation of molecular function | 3 | 1 |
GO:0050790 | regulation of catalytic activity | 3 | 1 |
GO:0051336 | regulation of hydrolase activity | 4 | 1 |
GO:0051345 | positive regulation of hydrolase activity | 5 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065009 | regulation of molecular function | 2 | 1 |
GO:0090630 | activation of GTPase activity | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005096 | GTPase activator activity | 4 | 1 |
GO:0008047 | enzyme activator activity | 3 | 1 |
GO:0030234 | enzyme regulator activity | 2 | 1 |
GO:0030695 | GTPase regulator activity | 4 | 1 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 3 | 1 |
GO:0098772 | molecular function regulator activity | 1 | 1 |
GO:0140677 | molecular function activator activity | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 10 | 14 | PF00656 | 0.476 |
CLV_C14_Caspase3-7 | 98 | 102 | PF00656 | 0.455 |
CLV_NRD_NRD_1 | 381 | 383 | PF00675 | 0.542 |
CLV_PCSK_SKI1_1 | 110 | 114 | PF00082 | 0.657 |
CLV_PCSK_SKI1_1 | 284 | 288 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 383 | 387 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 394 | 398 | PF00082 | 0.431 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.427 |
DEG_APCC_DBOX_1 | 283 | 291 | PF00400 | 0.464 |
DOC_CDC14_PxL_1 | 369 | 377 | PF14671 | 0.543 |
DOC_MAPK_gen_1 | 22 | 31 | PF00069 | 0.589 |
DOC_MAPK_MEF2A_6 | 41 | 48 | PF00069 | 0.406 |
DOC_USP7_MATH_1 | 331 | 335 | PF00917 | 0.492 |
LIG_14-3-3_CanoR_1 | 140 | 147 | PF00244 | 0.504 |
LIG_14-3-3_CanoR_1 | 240 | 250 | PF00244 | 0.492 |
LIG_Actin_WH2_2 | 9 | 26 | PF00022 | 0.463 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.610 |
LIG_BRCT_BRCA1_1 | 135 | 139 | PF00533 | 0.715 |
LIG_EH1_1 | 106 | 114 | PF00400 | 0.659 |
LIG_FHA_1 | 352 | 358 | PF00498 | 0.357 |
LIG_FHA_1 | 375 | 381 | PF00498 | 0.538 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.563 |
LIG_FHA_2 | 106 | 112 | PF00498 | 0.666 |
LIG_FHA_2 | 298 | 304 | PF00498 | 0.444 |
LIG_FHA_2 | 54 | 60 | PF00498 | 0.606 |
LIG_LIR_Gen_1 | 300 | 309 | PF02991 | 0.492 |
LIG_LIR_Gen_1 | 62 | 72 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 136 | 142 | PF02991 | 0.717 |
LIG_LIR_Nem_3 | 247 | 252 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 300 | 305 | PF02991 | 0.436 |
LIG_LIR_Nem_3 | 62 | 68 | PF02991 | 0.459 |
LIG_NRBOX | 229 | 235 | PF00104 | 0.492 |
LIG_Pex14_2 | 279 | 283 | PF04695 | 0.357 |
LIG_PTB_Apo_2 | 66 | 73 | PF02174 | 0.598 |
LIG_PTB_Phospho_1 | 66 | 72 | PF10480 | 0.591 |
LIG_Rb_LxCxE_1 | 364 | 378 | PF01857 | 0.545 |
LIG_REV1ctd_RIR_1 | 310 | 318 | PF16727 | 0.492 |
LIG_SH2_CRK | 168 | 172 | PF00017 | 0.618 |
LIG_SH2_CRK | 220 | 224 | PF00017 | 0.548 |
LIG_SH2_CRK | 344 | 348 | PF00017 | 0.492 |
LIG_SH2_CRK | 35 | 39 | PF00017 | 0.414 |
LIG_SH2_CRK | 40 | 44 | PF00017 | 0.375 |
LIG_SH2_STAP1 | 344 | 348 | PF00017 | 0.492 |
LIG_SH2_STAP1 | 392 | 396 | PF00017 | 0.596 |
LIG_SH2_STAP1 | 72 | 76 | PF00017 | 0.642 |
LIG_SH2_STAT5 | 195 | 198 | PF00017 | 0.477 |
LIG_SH2_STAT5 | 220 | 223 | PF00017 | 0.499 |
LIG_SH2_STAT5 | 329 | 332 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 367 | 370 | PF00017 | 0.539 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.398 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.633 |
LIG_SH3_3 | 159 | 165 | PF00018 | 0.767 |
LIG_SH3_3 | 283 | 289 | PF00018 | 0.492 |
LIG_TRAF2_1 | 185 | 188 | PF00917 | 0.563 |
LIG_TRAF2_1 | 56 | 59 | PF00917 | 0.630 |
LIG_TYR_ITIM | 218 | 223 | PF00017 | 0.340 |
LIG_TYR_ITIM | 38 | 43 | PF00017 | 0.525 |
LIG_WRC_WIRS_1 | 112 | 117 | PF05994 | 0.581 |
LIG_WW_1 | 32 | 35 | PF00397 | 0.464 |
MOD_CK1_1 | 116 | 122 | PF00069 | 0.536 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.584 |
MOD_CK1_1 | 307 | 313 | PF00069 | 0.486 |
MOD_CK1_1 | 351 | 357 | PF00069 | 0.492 |
MOD_CK1_1 | 390 | 396 | PF00069 | 0.443 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.552 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.760 |
MOD_CK2_1 | 122 | 128 | PF00069 | 0.497 |
MOD_CK2_1 | 297 | 303 | PF00069 | 0.379 |
MOD_CK2_1 | 349 | 355 | PF00069 | 0.492 |
MOD_CK2_1 | 53 | 59 | PF00069 | 0.630 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.678 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.669 |
MOD_GlcNHglycan | 128 | 132 | PF01048 | 0.623 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.503 |
MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.567 |
MOD_GlcNHglycan | 156 | 159 | PF01048 | 0.474 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.609 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.542 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.451 |
MOD_GlcNHglycan | 243 | 246 | PF01048 | 0.492 |
MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.797 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.406 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.780 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.408 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.483 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.724 |
MOD_N-GLC_1 | 221 | 226 | PF02516 | 0.547 |
MOD_NEK2_1 | 113 | 118 | PF00069 | 0.663 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.458 |
MOD_NEK2_1 | 282 | 287 | PF00069 | 0.351 |
MOD_NEK2_1 | 349 | 354 | PF00069 | 0.492 |
MOD_NEK2_1 | 375 | 380 | PF00069 | 0.314 |
MOD_NEK2_1 | 67 | 72 | PF00069 | 0.489 |
MOD_NEK2_2 | 105 | 110 | PF00069 | 0.621 |
MOD_NEK2_2 | 135 | 140 | PF00069 | 0.502 |
MOD_NEK2_2 | 245 | 250 | PF00069 | 0.492 |
MOD_PIKK_1 | 257 | 263 | PF00454 | 0.415 |
MOD_PKA_2 | 245 | 251 | PF00069 | 0.492 |
MOD_PKA_2 | 387 | 393 | PF00069 | 0.554 |
MOD_Plk_1 | 221 | 227 | PF00069 | 0.546 |
MOD_Plk_1 | 24 | 30 | PF00069 | 0.515 |
MOD_Plk_1 | 375 | 381 | PF00069 | 0.246 |
MOD_Plk_1 | 53 | 59 | PF00069 | 0.490 |
MOD_Plk_2-3 | 292 | 298 | PF00069 | 0.412 |
MOD_Plk_4 | 245 | 251 | PF00069 | 0.412 |
MOD_Plk_4 | 304 | 310 | PF00069 | 0.383 |
MOD_Plk_4 | 387 | 393 | PF00069 | 0.437 |
TRG_ENDOCYTIC_2 | 220 | 223 | PF00928 | 0.544 |
TRG_ENDOCYTIC_2 | 291 | 294 | PF00928 | 0.339 |
TRG_ENDOCYTIC_2 | 344 | 347 | PF00928 | 0.369 |
TRG_ENDOCYTIC_2 | 35 | 38 | PF00928 | 0.430 |
TRG_ENDOCYTIC_2 | 40 | 43 | PF00928 | 0.364 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.633 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7WY95 | Leishmania donovani | 94% | 100% |
A0A422NHQ9 | Trypanosoma rangeli | 38% | 100% |
A4HDF1 | Leishmania braziliensis | 85% | 100% |
A4I0T4 | Leishmania infantum | 94% | 100% |
D0A763 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
Q4QAN8 | Leishmania major | 94% | 100% |
V5BAM9 | Trypanosoma cruzi | 37% | 92% |